Manufacturing and Production

Showing 15 posts of 5863 posts found.

novartis_appointment

New Managing Director of UK & Ireland for Novartis

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …
donald_trump_september_3_2015

What does Trump’s victory mean for the pharma, biotech and healthcare sectors?

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Trump

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …
614px-flexed_plastic_display

Plastic electronics to bring “mind-blowing” developments for pharma

February 14, 2017 Manufacturing and Production, Research and Development plastic electronics

Plastic electronics could be the next big thing for pharma production and treatment , according to a new report on …
down_arrow

Hepatitis C market set for slump as cure rates rise

February 14, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Gilead, hepatitis C

Objectively, it is the pharmaceutical industries intention to find cures for diseases and to aid patients to live a full …
gsk_boronia_australia

GSK unveils strong showing for twin-drug HIV treatment

February 14, 2017 Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay

GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …
marathon_logo

Marathon’s major misstep shows that drug pricing debate is here to stay

February 14, 2017 Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Emflaza, marathon

Marathon Pharmaceuticals’ approval, last week, by the FDA for its treatment for Duchenne muscular dystrophy would usually have been cause …
allergan

Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal

February 13, 2017 Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq

Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …
headquarters_2_web

Lilly €200m expansion of Cork site under review

February 13, 2017 Manufacturing and Production, Sales and Marketing Eli Lilly, Ireland, cork

Eli Lilly’s planned €200m investment to its manufacturing plant in Kindsdale, County Cork, is now under-review. The expansion would bring …
erez_vigodman

Teva’s Vigodman becomes third CEO to leave in 5 years

February 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …
thomas-cueni

Thomas Cueni named as new IFPMA Director General

February 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA

Thomas Cueni has become the new Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and will …
europe-633476_960_720

Top five European countries by pharmaceutical spending per capita

February 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing European Pharmaceutical, pharmaceutical market, price

With pricing never far from the news and yet more news stories emerging around the inflated prices of certain generics …

Sanofi & Regeneron deflect Amgen’s legal marketing block on Praluent

February 9, 2017 Manufacturing and Production, Sales and Marketing Amgen, Regeneron, Repatha, Sanofi, praluent

Sanofi and Regeneron have successfully won in a US Court ruling calling for the suspension of the permanent injunction of …
The Gateway to Local Adoption Series

Latest content